Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

50.2K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.2K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.2K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

1.5K
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.5K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

2.7K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low-threshold SARS-CoV-2 testing facility for hospital staff: Prevention of COVID-19 outbreaks?

International journal of hygiene and environmental health·2020
Same author

Rapid point-of-care testing for SARS-CoV-2 in a community screening setting shows low sensitivity.

Public health·2020
Same author

Fc receptor-mediated phagocytosis in tissues as a potent mechanism for preventive and therapeutic HIV vaccine strategies.

Mucosal immunology·2016
Same author

Are there HLA combinations typical supporting for or making resistant against aggressive and/or chronic periodontitis?

Journal of periodontal research·2003
Same author

A clinical and molecular study of a Bedouin family with dysmegakaryopoiesis, mild anemia, and neutropenia cured by bone marrow transplantation.

European journal of haematology·2003
Same author

Anesthesiologist's role in bowel relaxation for artificial bladder construction.

Acta anaesthesiologica Scandinavica·2003
Same journal

Value of Genetically Rare Cord Blood Units Beyond Conventional Quality Metrics.

HLA·2026
Same journal

Characterisation of the Novel HLA-B*07:05:15 Allele by Sequencing-Based Typing.

HLA·2026
Same journal

Identification of the Novel HLA-C*03:536:02 Allele in a Chinese Cord Blood Donor.

HLA·2026
Same journal

Characterisation of the Novel HLA-DQB1*03:618 Allele by Sequencing-Based Typing.

HLA·2026
Same journal

Identification of the Novel HLA-A*01:510 Allele Through Next-Generation Sequencing.

HLA·2026
Same journal

Identification of the HLA-B*07:02:112 Allele in a Brazilian Individual by Next-Generation Sequencing.

HLA·2026
See all related articles

Related Experiment Video

Updated: Mar 15, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

3.0K

Barriers to HIV Cure.

J Stein1, M Storcksdieck Genannt Bonsmann2, H Streeck2,3

  • 1Institute for HIV Research, University Hospital Essen, University Duisburg-Essen, Essen, Germany. hendrik.streeck@uk-essen.de.

HLA
|September 14, 2016
PubMed
Summary
This summary is machine-generated.

Human immunodeficiency virus (HIV) persists in reservoirs, evading treatment. Identifying and overcoming these sanctuaries is crucial for eradicating HIV and preventing AIDS-related illnesses.

Keywords:
HIVcellular barriersimmunological barriers

More Related Videos

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

18.5K
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

19.4K

Related Experiment Videos

Last Updated: Mar 15, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

3.0K
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

18.5K
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

19.4K

Area of Science:

  • Virology
  • Immunology
  • Infectious Diseases

Background:

  • Over 70 million people infected with HIV and 38 million deaths from AIDS-related illnesses since the epidemic began.
  • Highly active antiretroviral therapy (HAART) has saved millions but cannot eradicate HIV due to latent reservoirs.
  • Latent HIV reservoirs can reactivate, producing infectious viral particles and hindering complete eradication.

Purpose of the Study:

  • To review recent findings on potential HIV sanctuaries within infected individuals.
  • To address potential strategies for overcoming immunological barriers posed by viral reservoirs.

Main Methods:

  • Review of recent scientific literature on HIV reservoirs and sanctuaries.
  • Analysis of cellular, anatomical, and microanatomical locations where HIV persists.
  • Examination of immunological factors contributing to viral persistence.

Main Results:

  • Identification of various cellular and anatomical sanctuaries where HIV remains undetected.
  • Understanding the mechanisms by which these reservoirs evade the immune system.
  • Highlighting the significant obstacle these sanctuaries present for HIV eradication.

Conclusions:

  • HIV reservoirs in sanctuaries are a major barrier to complete eradication.
  • Further research into these sanctuaries is essential for developing effective cure strategies.
  • Overcoming immunological barriers is key to achieving an HIV-free future.